{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:30:59Z","timestamp":1790616659295,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mechanical circulatory support (MCS) devices are increasingly used to provide hemodynamic stability for patients with severe coronary artery disease, comorbidities, and\/or impaired hemodynamics during high-risk percutaneous coronary interventions (PCI). Vascular access site complications, particularly those due to the use of large-bore sheaths, may limit outcomes in these patients. The aim of this study was to investigate the incidence and predictors of vascular complications in protected high-risk PCIs. Therefore, we included patients undergoing high-risk PCI with an Impella device from January 2016 to August 2018. Vascular complications were graded according to \u2018Valve Academic Research Consortium-2\u2019, a definition routinely used in transcatheter valve implantation procedures. In total, 61 patients (mean age 72\u2009\u00b1\u200911 years, 79% male, SYNTAX score 33\u2009\u00b1\u20097) were included, and angiographic- and fluoroscopic-guided vascular access was used for Impella implantation in all patients. Major vascular complications occurred in 5 male patients (8%). All major vascular complications were treated conservatively without the need for surgical intervention, and only one patient received a transfusion of three erythrocyte concentrates. Regression analysis revealed that patients with peripheral arterial disease of the lower extremities are at higher risk of major vascular complications. In conclusion, the utilization of Impella using a standardized protocol for angiographic- and fluoroscopic-guided vascular access was associated with a low rate of vascular complications.<\/jats:p>","DOI":"10.1038\/s41598-019-54277-w","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T11:03:21Z","timestamp":1574939001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Access site complications following Impella-supported high-risk percutaneous coronary interventions"],"prefix":"10.1038","volume":"9","author":[{"given":"Laura","family":"Johannsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Mahabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Totzeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9966-6886","authenticated-orcid":false,"given":"Rolf Alexander","family":"J\u00e1nosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Al-Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"54277_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jcin.2016.02.046","volume":"9","author":"TM Atkinson","year":"2016","unstructured":"Atkinson, T. M. et al. A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. JACC Cardiovasc Interv 9, 871\u2013883 (2016).","journal-title":"JACC Cardiovasc Interv"},{"key":"54277_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jcin.2014.07.030","volume":"8","author":"A Myat","year":"2015","unstructured":"Myat, A. et al. Percutaneous circulatory assist devices for high-risk coronary intervention. JACC Cardiovasc Interv 8, 229\u2013244 (2015).","journal-title":"JACC Cardiovasc Interv"},{"key":"54277_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcin.2008.11.005","volume":"2","author":"SR Dixon","year":"2009","unstructured":"Dixon, S. R. et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2, 91\u201396 (2009).","journal-title":"JACC Cardiovasc Interv"},{"key":"54277_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","volume":"126","author":"WW O\u2019Neill","year":"2012","unstructured":"O\u2019Neill, W. W. et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126, 1717\u20131727 (2012).","journal-title":"Circulation"},{"key":"54277_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ccd.26979","volume":"90","author":"T Schreiber","year":"2017","unstructured":"Schreiber, T. et al. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry. Catheter Cardiovasc Interv 90, 576\u2013581 (2017).","journal-title":"Catheter Cardiovasc Interv"},{"key":"54277_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ccd.23403","volume":"80","author":"B Maini","year":"2012","unstructured":"Maini, B. et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv 80, 717\u2013725 (2012).","journal-title":"Catheter Cardiovasc Interv"},{"key":"54277_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","volume":"92","author":"TD Kinnaird","year":"2003","unstructured":"Kinnaird, T. D. et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92, 930\u2013935 (2003).","journal-title":"Am J Cardiol"},{"key":"54277_CR8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","volume":"49","author":"SV Manoukian","year":"2007","unstructured":"Manoukian, S. V. et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49, 1362\u20131368 (2007).","journal-title":"J Am Coll Cardiol"},{"key":"54277_CR9","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.jacc.2009.09.018","volume":"54","author":"KD Sjauw","year":"2009","unstructured":"Sjauw, K. D. et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J. Am. Coll. Cardiol. 54, 2430\u20132434 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"54277_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ijcard.2015.10.063","volume":"202","author":"DM Ouweneel","year":"2016","unstructured":"Ouweneel, D. M. et al. Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial. Int J Cardiol 202, 894\u2013896 (2016).","journal-title":"Int J Cardiol"},{"key":"54277_CR11","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","volume":"38","author":"H Thiele","year":"2017","unstructured":"Thiele, H. et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. European Heart Journal 38, 3523\u20133531 (2017).","journal-title":"European Heart Journal"},{"key":"54277_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joic.12080","volume":"27","author":"WW O\u2019Neill","year":"2014","unstructured":"O\u2019Neill, W. W. et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J. Interv. Cardiol. 27, 1\u201311 (2014).","journal-title":"J. Interv. Cardiol."},{"key":"54277_CR13","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","volume":"42","author":"AP Kappetein","year":"2012","unstructured":"Kappetein, A. P. et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42, S45\u201360 (2012).","journal-title":"Eur J Cardiothorac Surg"},{"issue":"19","key":"54277_CR14","first-page":"33521","volume":"S0167-5273","author":"F Al-Rashid","year":"2019","unstructured":"Al-Rashid, F. et al. Safety and efficacy of a novel algorithm to guide decision-making in high-risk interventional coronary procedures. Int J Cardiol S0167-5273(19), 33521\u20131 (2019).","journal-title":"Int J Cardiol"},{"key":"54277_CR15","unstructured":"Neumann, F. J. et al. ESC\/EACTS Guidelines on myocardial revascularization. European Heart Journal, 1\u201396 (2018)."},{"key":"54277_CR16","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","volume":"65","author":"CS Rihal","year":"2015","unstructured":"Rihal, C. S. et al. 2015 SCAI\/ACC\/HFSA\/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d\u2019intervention. J. Am. Coll. Cardiol. 65, e7\u2013e26 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"54277_CR17","doi-asserted-by":"publisher","first-page":"E139","DOI":"10.1002\/ccd.24326","volume":"81","author":"P Kahlert","year":"2013","unstructured":"Kahlert, P. et al. Suture-mediated arterial access site closure after transfemoral aortic valve implantation. Catheter Cardiovasc Interv 81, E139\u2013150 (2013).","journal-title":"Catheter Cardiovasc Interv"},{"key":"54277_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4244\/EIJV10I10A206","volume":"10","author":"F Al-Rashid","year":"2015","unstructured":"Al-Rashid, F., Nix, C., Erbel, R. & Kahlert, P. Tools & Techniques - clinical: percutaneous catheter-based left ventricular support using the Impella CP. EuroIntervention 10, 1247\u20131249 (2015).","journal-title":"EuroIntervention"},{"key":"54277_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans, V. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal 39, 763\u2013816 (2018).","journal-title":"European Heart Journal"},{"key":"54277_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijcard.2010.08.039","volume":"153","author":"KE Iliodromitis","year":"2011","unstructured":"Iliodromitis, K. E. et al. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support. Int J Cardiol 153, 59\u201363 (2011).","journal-title":"Int J Cardiol"},{"issue":"3","key":"54277_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00380-018-1266-6","volume":"34","author":"EV Castle","year":"2019","unstructured":"Castle, E. V. et al. Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis. Heart Vessels 34(3), 419\u2013426 (2019).","journal-title":"Heart Vessels"},{"key":"54277_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.hlc.2015.06.826","volume":"25","author":"J Wlodarczyk","year":"2016","unstructured":"Wlodarczyk, J. et al. Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia. Heart Lung Circ 25, 107\u2013117 (2016).","journal-title":"Heart Lung Circ"},{"issue":"2","key":"54277_CR23","first-page":"202","volume":"1","author":"Brendan J. Doyle","year":"2008","unstructured":"Doyle, B. J. et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv 1, 202\u2013209 (2008).","journal-title":"JACC: Cardiovascular Interventions"},{"key":"54277_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejim.2018.08.010","volume":"59","author":"L De Luca","year":"2018","unstructured":"De Luca, L. et al. Trends in management and outcome of patients with non-ST elevation acute coronary syndromes and peripheral arterial disease. Eur J Intern Med 59, 70\u201376 (2018).","journal-title":"Eur J Intern Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54277-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54277-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54277-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:41:19Z","timestamp":1671295279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54277-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54277"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54277-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17844"}}